{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:05:29Z","timestamp":1790287529544,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e00953","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:52:11Z","timestamp":1785145931000},"page":"e00953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial"],"prefix":"10.1016","volume":"23","author":[{"given":"Xiaolu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanye","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxia","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuneng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10360","key":"10.1016\/j.neurot.2026.e00953_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00953_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jnnp-2024-333978","article-title":"Multiple metal exposures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control study","volume":"96","author":"Jang","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00953_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-021-00510-y","article-title":"Edaravone activates the GDNF\/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells","volume":"17","author":"Li","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00953_bib4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/brain\/awae039","article-title":"How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?","volume":"147","author":"Odierna","year":"2024","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00953_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004092","article-title":"Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: a nationwide nested case-control study in Sweden","volume":"19","author":"Sun","year":"2022","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00953_bib6","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41565-024-01683-5","article-title":"Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms","volume":"19","author":"Sun","year":"2024","journal-title":"Nat Nanotechnol"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00953_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1474-4422(24)00216-3","article-title":"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blind, placebo-controlled, multiple ascending dose study","volume":"23","author":"van den Berg","year":"2024","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00953_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jnnp-2019-322317","article-title":"Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study","volume":"91","author":"Xu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00953_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","article-title":"Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study","volume":"17","author":"Fang","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00953_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00953_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","article-title":"Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis","volume":"79","author":"Witzel","year":"2022","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00953_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00953_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24050","article-title":"Icariin prevents methylmercury-induced experimental neurotoxicity: evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations","volume":"10","author":"Sharma","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00953_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098866","article-title":"Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00953_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/tox.23738","article-title":"Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating \u03b17nAChR-mediated microglial polarization","volume":"38","author":"Huo","year":"2023","journal-title":"Environ Toxicol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00953_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jafc.5b05841","article-title":"Anti-inflammatory and antinociceptive constituents of Atractylodes japonica Koidzumi","volume":"64","author":"Chen","year":"2016","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.neurot.2026.e00953_bib17","article-title":"Catalpol rescues cognitive deficits by attenuating amyloid \u03b2 plaques and neuroinflammation","volume":"165","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00953_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/1673-5374.175053","article-title":"Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra","volume":"11","author":"Liang","year":"2016","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00953_bib19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41598-018-19923-9","article-title":"Fingerprint analysis of Huolingshengji formula and its neuroprotective effects in SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00953_bib20","first-page":"23","article-title":"Effect of \u201cHuoling shengji formula\u201din treatment of amyotrophic lateral sclerosis. Acad J Shanghai univ tradit","volume":"30","author":"Sui","year":"2016","journal-title":"Chin Med"},{"key":"10.1016\/j.neurot.2026.e00953_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fnagi.2016.00246","article-title":"Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China","volume":"8","author":"Chen","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00953_bib22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ana.26760","article-title":"Neutrophils are associated with higher risk of incident amyotrophic lateral sclerosis in a BMI- and age-dependent manner","volume":"94","author":"Cao","year":"2023","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00953_bib23","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.4103\/NRR.NRR-D-24-01081","article-title":"The role of the peripheral immune system in mediating axonal dysfunction in early-stage amyotrophic lateral sclerosis: an age- and sex-based analysis","volume":"21","author":"Wang","year":"2026","journal-title":"Neural Regen Res"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00953_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0531-5565(98)00012-6","article-title":"Age-associated differences in neutrophil oxidative burst (chemiluminescence)","volume":"33","author":"Braga","year":"1998","journal-title":"Exp Gerontol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00953_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0047-6374(03)00017-4","article-title":"Neutrophil immunity of the elderly","volume":"124","author":"Schr\u00f6der","year":"2003","journal-title":"Mech Ageing Dev"},{"issue":"1-2","key":"10.1016\/j.neurot.2026.e00953_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/21678421.2019.1655060","article-title":"Stage-specific riluzole effect in amyotrophic lateral sclerosis: a retrospective study","volume":"21","author":"Thakore","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00953_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/14660820410020187","article-title":"Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial","volume":"5","author":"Leigh","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00953_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp-2016-314661","article-title":"What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis","volume":"88","author":"Rooney","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurot.2026.e00953_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1153973","article-title":"\u201cHuoling Shengji granule\u201d for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial","volume":"15","author":"Liu","year":"2023","journal-title":"Front Aging Neurosci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:07:55Z","timestamp":1790125675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926001236"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00953","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00953"}}